キーワード一覧
0-9
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1001 | 14-3-3 |
1002 | 3-D culture |
1003 | 4-HNE |
1004 | 5-FU |
1005 | 8-OH-Gua |
A
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1006 | AAV vector |
1007 | ABC transporter |
1008 | ABCG2 |
1009 | Acrylamide |
1010 | Actin |
1011 | Adenoma / adenocarcinoma |
1012 | Adenomatous polyposis coli |
1013 | Adenovirus |
1014 | Adenovirus vector |
1015 | Adipocyte |
1016 | Adjuvant therapy |
1017 | Aging |
1018 | Ah receptor |
1019 | Akt |
1020 | Alcohol |
1021 | Allogeneic transplantation |
1022 | Alpha 1 acid glycoprotein |
1023 | Alpha fetoprotein |
1024 | Alternative splicing |
1025 | AMF |
1026 | AML |
1027 | AMP-activated protein kinase |
1028 | Anchorage dependent growth |
1029 | Androgen |
1030 | Androgen receptor |
1031 | Aneuploidy |
1032 | Angiogenesis |
1033 | Angiogenesis inhibition |
1034 | Animal model |
1035 | Annexin |
1036 | Anthracycline |
1037 | Anti cancer drug |
1038 | Anti metabolight |
1039 | Antibody |
1040 | Antioxidants |
1041 | Antisense |
1042 | Antitumor activity |
1043 | Antitumor CTL |
1044 | Anti-tumor promoter |
1045 | AP-1 |
1046 | APC |
1047 | Apoptosis |
1048 | Apoptosis related gene |
1049 | ARF |
1050 | Arf6 |
1051 | Array CGH |
1052 | Arsenic |
1053 | Asbestos |
1054 | Ascorbic acid |
1055 | ASK1 |
1056 | ATL |
1057 | ATM |
1058 | Aurora kinase |
1059 | Autophagy |
1060 | Azoxymethane |
B
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1061 | Bacteria |
1062 | B-cell lymphoma |
1063 | BCG |
1064 | Bcl-2 |
1065 | Bcl-x |
1066 | Bcr-Abl |
1067 | Beta catenin |
1068 | BHP |
1069 | Bile |
1070 | Bile acid |
1071 | Biliary tract carcinoma |
1072 | Bim |
1073 | Bioinformatics |
1074 | Biomarker |
1075 | Biopsy |
1076 | Biostatistics |
1077 | Birth cohort |
1078 | Bispecific diabody |
1079 | Bladder |
1080 | Bladder cancer |
1081 | Blood flow |
1082 | BMI-1 |
1083 | BMP |
1084 | BNCT |
1085 | Body mass index |
1086 | Bone marrow |
1087 | Bone marrow transplantation |
1088 | Bone metastases |
1089 | BRAF |
1090 | Brain metastasis |
1091 | Brain tumor |
1092 | BRCA1/2 |
1093 | Breast cancer |
1094 | Bystander effect |
C
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1095 | Cachexia |
1096 | Cadherin |
1097 | CagA |
1098 | calcium channel |
1099 | Cancer Antigen |
1100 | cancer control |
1101 | Cancer genetics |
1102 | Cancer prevention |
1103 | Cancer registry |
1104 | Cancer risk assessment |
1105 | cancer stem cell |
1106 | Cancer vaccine |
1107 | Cap43 |
1108 | CAR |
1109 | Carbohydrate antigen |
1110 | Carcinogen |
1111 | Carcinogenesis |
1112 | carcinosarcoma |
1113 | Case-control study |
1114 | Caspase |
1115 | catechin |
1116 | Cathepsin |
1117 | CD155 |
1118 | CD44 |
1119 | CD8 |
1120 | CD98 |
1121 | Cdk |
1122 | Cdx |
1123 | CEA |
1124 | Cell adhesion |
1125 | cell adhesion molecules |
1126 | Cell cycle |
1127 | Cell cycle arrest |
1128 | Cell cycle checkpoint |
1129 | Cell death |
1130 | Cell density |
1131 | Cell differentiation |
1132 | Cell line |
1133 | Cell migration /motility |
1134 | Cell polarity |
1135 | Cell therapy |
1136 | centromere protein |
1137 | Centrosome |
1138 | Cervical cancer |
1139 | CGH-array |
1140 | Chaperone |
1141 | Chemokine |
1142 | chemokine receptor |
1143 | Chemoprevention |
1144 | chemoradiotherapy |
1145 | Chemosensitivity |
1146 | Chemosensitivity prediction |
1147 | Chemotherapy |
1148 | chemotherapy-induced alopecia |
1149 | Cholangiocarcinoma |
1150 | Cholesterol |
1151 | chromatin immunoprecipitation |
1152 | Chromatin remodeling |
1153 | Chromosomal instability |
1154 | Chromosome |
1155 | Chromosome aberration |
1156 | Chromosome translocation |
1157 | Cisplatin |
1158 | C-kit |
1159 | Claudin |
1160 | Clinical trial |
1161 | Clock |
1162 | C-MET |
1163 | CML |
1164 | C-Myc |
1165 | cofilin |
1166 | Cohort study |
1167 | colon cancer |
1168 | Colon carcinogenesis |
1169 | colonic cancer |
1170 | Colorectal adenoma |
1171 | Colorectal cancer |
1172 | Combination effect |
1173 | Computer simulation |
1174 | Connexin |
1175 | COX-2 |
1176 | CpG DNA |
1177 | CpG methylation |
1178 | CTL |
1179 | Curcumin |
1180 | Cyclin |
1181 | cytarabine |
1182 | Cytodiagnosis |
1183 | Cytokeratin |
1184 | Cytokine |
1185 | Cytotoxic activity |
D
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1186 | DDS |
1187 | Dedifferentiation |
1188 | Demethylation |
1189 | Dendritic cell |
1190 | Dendritic cell therapy |
1191 | Diabetes mellitus |
1192 | Diagnosis |
1193 | Dietary fat |
1194 | Differentiation |
1195 | DMBA |
1196 | DNA adduct |
1197 | DNA damage |
1198 | DNA methylation |
1199 | DNA methyltransferase-1 |
1200 | DNA microarray |
1201 | DNA mismatch repair |
1202 | DNA polymerase |
1203 | DNA repair |
1204 | DNA Replication |
1205 | DNA synthesis |
1206 | DNA tumor viruses |
1207 | DNA vaccine |
1208 | DNA-PK |
1209 | Double strand break |
1210 | Doxorubicin |
1211 | Drug discovery |
1212 | Drug resistance |
1213 | Drug response |
E
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1214 | E-cadherin |
1215 | E2F |
1216 | EBV |
1217 | Economic evaluation |
1218 | education |
1219 | EGF receptor |
1220 | Embryonic stem cell |
1221 | EMT |
1222 | Endocytosis |
1223 | Endometrial cancer |
1224 | Endoplasmic reticulum |
1225 | Endothelial cell |
1226 | Endothelin |
1227 | Eph/Eph receptor |
1228 | Epidemiology |
1229 | Epigenetics |
1230 | Epithelial Mesenchymal Transition |
1231 | EPR effect |
1232 | ER stress |
1233 | ErbB-2/ HER2 /Neu |
1234 | ERCC1 |
1235 | ERK |
1236 | Esophageal cancer |
1237 | Estrogen |
1238 | Estrogen receptor |
1239 | Ets |
1240 | EVI1 |
1241 | Ewing sarcoma |
1242 | EWS-Fli1 |
1243 | exercise training |
1244 | Exosome |
1245 | Extracellular vesicle |
1246 | EZH2 |
F
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1247 | FAK |
1248 | Familial cancer |
1249 | Fanconi Anemia |
1250 | Fatty acid |
1251 | F-box protein |
1252 | FGF |
1253 | Fibronectin |
1254 | FISH |
1255 | FLT |
1256 | Flt3Ligand |
1257 | Free radical |
1258 | FRET |
1259 | Fucosylated glycoforms |
1260 | Fusion |
G
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1261 | G protein |
1262 | G1 arrest |
1263 | GADD45 |
1264 | galectin-3 |
1265 | Gallbladder cancer |
1266 | gamma delta T cell |
1267 | Ganglioside |
1268 | Gastric cancer |
1269 | Gastric carcinogenesis |
1270 | Gastrointestinal cancer |
1271 | Gastrointestinal stromal tumor |
1272 | GATA |
1273 | G-CSF |
1274 | GDNF |
1275 | GEF |
1276 | gefitinib |
1277 | Gemcitabine |
1278 | Gene amplification |
1279 | Gene delivery |
1280 | Gene expression |
1281 | Gene regulation |
1282 | Gene therapy |
1283 | Genetic alteration |
1284 | Genetic diagnosis |
1285 | Genetic factor |
1286 | Genome |
1287 | genome imprinting |
1288 | Genomic instability |
1289 | genomics |
1290 | genotoxicity test |
1291 | germ cell tumor |
1292 | Glioblastoma |
1293 | Glioma |
1294 | Glucose deprivation |
1295 | Glutathione |
1296 | Glutathione S-transferase |
1297 | Glycogen synthase kinase-3 |
1298 | Glycolysis |
1299 | glycosylation |
1300 | Glycosyltransferase |
1301 | Glypican3 |
1302 | Green fluorescent protein |
1303 | Green tea |
1304 | Growth factor |
1305 | Gynecologic cancer |
H
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1306 | H2AX |
1307 | HBV |
1308 | HCV |
1309 | HDAC |
1310 | HDAC inhibitor |
1311 | Head and neck cancer |
1312 | Heat shock protein |
1313 | Heavy ion |
1314 | Hedgehog |
1315 | Helicobacter pylori |
1316 | Hematological malignancy |
1317 | Hematopoietic stem cell |
1318 | Heparan sulfate |
1319 | Heparanase |
1320 | Hepatoblastoma |
1321 | Hepatocarcinogenesis |
1322 | Hepatocellular carcinoma |
1323 | HER2 |
1324 | Herpes virus |
1325 | Heterochromatin |
1326 | Heterogeneity |
1327 | HGF |
1328 | HIF-1 |
1329 | Hippo pathway |
1330 | Histone acetylation |
1331 | Histone modification |
1332 | HLA |
1333 | HLH transcription factor |
1334 | HMG-CoA reductase inhibitor |
1335 | HNPCC |
1336 | HnRNP |
1337 | Homologous recombination |
1338 | Hormonal therapy |
1339 | HPV |
1340 | hTERT |
1341 | HTLV-1 |
1342 | Humanized antibody |
1343 | Hyaluronan |
1344 | Hyperplasia |
1345 | Hyperthermia |
1346 | Hypoxia |
I
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1347 | IFN |
1348 | IGF |
1349 | IGF-1 |
1350 | IGF-I receptor |
1351 | IGFBP-3 |
1352 | Ikaros |
1353 | IKK |
1354 | IL-1 beta |
1355 | IL-10 |
1356 | IL-12 |
1357 | IL-17 |
1358 | IL-18 |
1359 | IL-2 |
1360 | IL-6 |
1361 | imaging |
1362 | Immune cell therapy |
1363 | Immune checkpoint inhibitor |
1364 | Immune response |
1365 | Immune suppression |
1366 | Immunohistochemistry |
1367 | Immunotherapy |
1368 | in vivo imaging |
1369 | Inflammation |
1370 | inhibitor |
1371 | Integrin |
1372 | Interferon |
1373 | intestinal immune system |
1374 | Intestinal metaplasia |
1375 | Intratumor heterogeneity |
1376 | Invasion |
1377 | iPS cell |
1378 | Irinotecan |
1379 | Isothiocyanate derivatives |
J
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1380 | JNK |
1381 | JAK-STAT pathway |
K
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1382 | Kinase |
1383 | KRAS |
L
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1384 | Lactobacillus casei |
1385 | Laminin |
1386 | Laparoscopic surgery |
1387 | Lectin |
1388 | Leukemia |
1389 | Leukemogenesis |
1390 | Life-style |
1391 | linoleic acid |
1392 | Liposome |
1393 | Liver |
1394 | Liver carcinogenesis |
1395 | Liver cirrhosis |
1396 | Liver metastasis |
1397 | LMP1 |
1398 | LOH |
1399 | L-Tryptophan |
1400 | lung |
1401 | lung adenocarcinoma |
1402 | Lung cancer |
1403 | Lung carcinogenesis |
1404 | Lung Metastasis |
1405 | Lymph node metastasis |
1406 | lymphoma |
1407 | Lymphomagenesis |
1408 | Lymphoproliferative disorders |
M
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1409 | Macrophage |
1410 | Malignant lymphoma |
1411 | MALT lymphoma |
1412 | Mammary tumor |
1413 | MAPK |
1414 | Marker |
1415 | Mass Spectrometry |
1416 | MDM2 |
1417 | MDR |
1418 | medical oncologist |
1419 | Melanocyte |
1420 | Melanoma |
1421 | MEN |
1422 | Menin |
1423 | Mesenchymal Stem Cell |
1424 | Mesothelioma |
1425 | Metabolic activation |
1426 | Metalloprotease |
1427 | Metastasis |
1428 | methionine depletion |
1429 | Methylation |
1430 | MGMT |
1431 | Microarray |
1432 | microenvironment |
1433 | Micrometastasis |
1434 | microRNA |
1435 | Microsatellite instability |
1436 | Microtubule-associated protein |
1437 | Microtubule-Depolymerizing Agents |
1438 | Mismatch repair |
1439 | Mitochondria |
1440 | mitomycin C |
1441 | Mitosis |
1442 | MKL1 |
1443 | MKP |
1444 | MLL |
1445 | MLPA |
1446 | MMP |
1447 | Molecular epidemiology |
1448 | Molecular pathology |
1449 | Molecular target |
1450 | Molecular target therapy |
1451 | Monoclonal antibody |
1452 | Monocyte |
1453 | mRNA |
1454 | MSI |
1455 | mta1 |
1456 | MUC |
1457 | Mucin |
1458 | Multidrug resistance |
1459 | Multiple myeloma |
1460 | Multistep carcinogenesis |
1461 | Mutagenesis |
1462 | Mutant Frequency |
1463 | Mutation |
1464 | MYCN |
1465 | Myelodysplastic syndrome |
1466 | MYH |
1467 | Myofibroblast |
N
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1468 | N-myc |
1469 | Nanomedicine |
1470 | Nasopharyngeal carcinoma |
1471 | Natural compounds |
1472 | Nectin |
1473 | Neoadjuvant chemotherapy |
1474 | Neoantigen |
1475 | Neuroblastoma |
1476 | Neuroendocrine |
1477 | Neutrophils |
1478 | NF-kB |
1479 | NF1 |
1480 | Nitrogen oxide |
1481 | Nitrosamine |
1482 | NK cell |
1483 | NK lymphoma |
1484 | NKT cell |
1485 | Non-coding RNA |
1486 | Notch |
1487 | Nox1 |
1488 | Noxa |
1489 | Nrf2 |
1490 | NSAID |
1491 | Nuclear receptor |
1492 | Nuclear transport |
1493 | Nutrient deprivation |
1494 | NY-ESO-1 |
O
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1495 | Obesity |
1496 | OGG1 |
1497 | Oncogene |
1498 | Oncologist Education |
1499 | Oncolytic virus |
1500 | Oral cancer |
1501 | Organiod |
1502 | Orthotopic implantation |
1503 | Osteosarcoma |
1504 | Ovarian cancer |
1505 | Oxaliplatin |
1506 | Oxidative DNA damage |
1507 | Oxidative stress |
1508 | Oxygen consumption |
P
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1509 | P16 |
1510 | P21 |
1511 | P27 |
1512 | p38 MAPK |
1513 | P53 |
1514 | P53 knockout mouse |
1515 | P53 related gene |
1516 | P57 |
1517 | p63 |
1518 | P73 |
1519 | P75NTR |
1520 | Paclitaxel |
1521 | pain |
1522 | Pancreas |
1523 | Pancreatic cancer |
1524 | Parg |
1525 | Parp |
1526 | Pathology |
1527 | PAX family genes |
1528 | Paxillin |
1529 | PDGF |
1530 | PDGFRA |
1531 | PDX (Patient-derived xenograft) |
1532 | PEDF |
1533 | pediatrics |
1534 | Peptide |
1535 | Perineural invasion |
1536 | Periostin |
1537 | Peritoneal dissemination |
1538 | Peroxisome proliferator |
1539 | Personalized medicine |
1540 | PET |
1541 | Pharmacogenomics |
1542 | Pharmacokinetics |
1543 | Phase I study |
1544 | phenotype |
1545 | PhIP |
1546 | Phosphorylation |
1547 | Photodynamic therapy |
1548 | Physical Activity |
1549 | PI3-kinase |
1550 | PKC |
1551 | Platinum drug |
1552 | pleura |
1553 | podoplanin/Aggrus |
1554 | poly-ADP-ribose |
1555 | Polyamine |
1556 | Polycomb |
1557 | Polymeric drugs |
1558 | Polymorphism |
1559 | Polyphenol |
1560 | Post-transcriptional regulation |
1561 | PP2A |
1562 | PPAR |
1563 | Prevention Study |
1564 | Progesterone receptor |
1565 | Prognosis |
1566 | Progression |
1567 | Prostaglandin |
1568 | Prostanoid Receptor |
1569 | Prostate |
1570 | Prostate cancer |
1571 | Protease |
1572 | Proteasome |
1573 | proteasome inhibitor |
1574 | Protein kinase |
1575 | Protein kinase inhibitor |
1576 | Protein Phosphatase |
1577 | protein tyrosine phosphatase |
1578 | Protein-protein interaction |
1579 | Proteomics |
1580 | psychooncology |
1581 | psycho-oncology |
1582 | PTEN |
1583 | PU1 |
Q
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1584 | QOL |
1585 | Quantitative real time PCR |
1586 | Quiescence |
R
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1587 | Rac |
1588 | Rad |
1589 | Radiation |
1590 | Radioimmunotherapy |
1591 | Radiosensitivity |
1592 | Raf |
1593 | RANKL |
1594 | Ras |
1595 | RAS-GAP |
1596 | RB |
1597 | RCAS1 |
1598 | Reactive nitrogen species |
1599 | Reactive oxygen species |
1600 | Receptor tyrosine kinase |
1601 | RECK |
1602 | Recurrence |
1603 | regeneration |
1604 | regulatory T cell |
1605 | Renal cell carcinoma |
1606 | Replicon |
1607 | Ret |
1608 | Retinoic acid |
1609 | RGD peptide |
1610 | rhabdomyosarcoma |
1611 | Rho |
1612 | RhoGDI |
1613 | Risk factor |
1614 | RNA |
1615 | RNA interference |
1616 | RNA synthesis inhibitor |
1617 | RNA-binding protein |
1618 | RNF43 |
1619 | RUNX |
S
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1620 | S-1 |
1621 | S100 |
1622 | SAGE |
1623 | Salivary gland tumor |
1624 | Sarcoma |
1625 | Screening |
1626 | Second Cancer |
1627 | segmental duplication |
1628 | Selectin |
1629 | Semaphorin |
1630 | Seminoma |
1631 | Senescence |
1632 | Sensitivity test |
1633 | Sentinel node |
1634 | Septin |
1635 | SEREX |
1636 | serum markers |
1637 | Serum pepsinogen |
1638 | Shp1 |
1639 | SHPS-1 |
1640 | Sialic acid |
1641 | Sialidase |
1642 | sialyltransferase |
1643 | Signal pathway |
1644 | Signal transduction |
1645 | SIRT2 |
1646 | sister chromatid separation |
1647 | Skp2 |
1648 | SLPI |
1649 | Smad |
1650 | Small cell carcinoma |
1651 | small interfering RNA |
1652 | Small-cell lung cancer |
1653 | S-methylcysteine |
1654 | Smoking |
1655 | Snail |
1656 | SNP |
1657 | Social support |
1658 | SOCS |
1659 | Soft tissue tumor |
1660 | Sonodynamic therapy |
1661 | Sp1 |
1662 | Splice-site |
1663 | spontaneous carcinogenesis |
1664 | Squamous cell carcinoma |
1665 | Src |
1666 | SSX |
1667 | STAT3 |
1668 | stem cell |
1669 | Steroid |
1670 | Stomach |
1671 | Stromal |
1672 | Suicide gene |
1673 | sulfatase |
1674 | Sulfotransferase |
1675 | SUMO-1 |
1676 | Surgical treatment |
1677 | Survival |
1678 | Survivin |
1679 | Susceptibility gene |
1680 | SV40 |
1681 | SWI SNF complex |
1682 | synovial sarcoma |
1683 | Systems Biology |
1684 | SYT-SSX |
T
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1685 | T cell |
1686 | Tamoxifen |
1687 | Tankyrase |
1688 | Targeting |
1689 | Tat |
1690 | Tax |
1691 | Taxan derivative |
1692 | TCF4 |
1693 | TEL ETV6 |
1694 | TEL-AML1 |
1695 | Telomerase |
1696 | Telomere |
1697 | Testicular cancer |
1698 | TFPI-2 |
1699 | TGF-beta |
1700 | Th1 |
1701 | Thioredoxin |
1702 | Thymidine phosphorylase |
1703 | Thymidylate synthase |
1704 | Thyroid |
1705 | Thyroid cancer |
1706 | tiling array |
1707 | TM4SF |
1708 | TNF |
1709 | Tob |
1710 | Toll-like receptor |
1711 | Tongue cancer |
1712 | Topoisomerase |
1713 | Toremifene |
1714 | TPA |
1715 | TRAIL |
1716 | Transcription |
1717 | Transcription coupled repair |
1718 | transcription factors |
1719 | Transfection |
1720 | transformation |
1721 | Transgenic mouse |
1722 | Transgenic rat |
1723 | translation |
1724 | translational research |
1725 | translesion DNA synthesis |
1726 | transplantation |
1727 | transporter |
1728 | treatment |
1729 | tryptase |
1730 | TSC |
1731 | TSC-22 |
1732 | TSLC1 |
1733 | Tuberous sclerosis gene |
1734 | tubulin |
1735 | Tumor antigen |
1736 | Tumor growth |
1737 | Tumor Immunity |
1738 | Tumor marker |
1739 | Tumor progression |
1740 | Tumor Selectivity |
1741 | Tumor suppressor activity |
1742 | Tumor suppressor gene |
1743 | Tumorigenicity |
1744 | Tyrosin phospholylation |
1745 | Tyrosine kinase |
1746 | Tyrosine kinase inhibitor |
U
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1747 | Ubiquitin |
1748 | Ulcerative colitis |
1749 | ultrasound |
1750 | UPR |
1751 | Uterine cancer |
1752 | UV |
V
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1753 | Vaccine |
1754 | Vasculature |
1755 | VEGF |
1756 | VEGF-C |
1757 | VEGF-D |
1758 | VEGFR2 |
1759 | VEGFR-3 |
1760 | VHL |
1761 | Vinorelbine |
1762 | Viral therapy |
1763 | Virus vector |
1764 | Vitamin D3 |
1765 | Vitamin K |
W
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1766 | Wee1 |
1767 | Wilms tumor |
1768 | Wnt |
1769 | Wnt-5a |
1770 | WT1 |
X
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1771 | Xenograft |
Y
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1772 | YB-1 |
Z
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - ZCODE | キーワード |
---|---|
1773 | Zinc finger |